Catalpa Ventures
Venture capitalGrevenmacher · Pre-Seed–Series A · 5 people tracked
Find your way into Catalpa Ventures
536 people in our graph share verified history with the Catalpa Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Catalpa Ventures backs early-stage HealthTech founders using technology to address structural challenges in healthcare, including an aging population, a shrinking healthcare workforce, and rising costs. The firm invests from pre-seed to Series A, aiming to be the first institutional investor, with a focus on 'Extended Europe' — DACH, Benelux, and emerging hubs. It views digitalization as central to solving fundamental healthcare problems and considers young innovative companies both economically impactful and drivers of socially sustainable progress. Initial tickets range from €300k to €1.5M, with reserves held for follow-on investments through its Catalpa Health Fund I.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directoriesFrequently asked questions
- What stage does Catalpa Ventures invest at?
- Catalpa Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Catalpa Ventures's typical check size?
- Catalpa Ventures typically writes checks of $330K – $1.6M.
- What sectors does Catalpa Ventures focus on?
- Catalpa Ventures focuses on Digital Health, Healthtech, Medical Devices.
- Where is Catalpa Ventures located?
- Catalpa Ventures is headquartered in Grevenmacher, LU.
- Does Catalpa Ventures lead rounds?
- Yes, Catalpa Ventures leads investment rounds.
Media · Podcasts & interviews
featuring the teamLuxembourgOfficial - Interview with Thomas Goergen and Silke Sperling (Catalpa Ventures)
360Crossmedia · Thomas Goergen
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Kfund is a venture capital firm that invests in entrepreneurs building differentiated technology-based products and services.
Flare Capital Partners is a healthcare technology-focused venture firm that partners with founders building companies to improve outcomes, lower costs, and reshape healthcare delivery.









